Genome-wide association study of leukotriene modifier response in asthma

Heterogeneous therapeutic responses to leukotriene modifiers (LTMs) are likely due to variation in patient genetics. Although prior candidate gene studies implicated multiple pharmacogenetic loci, to date, no genome-wide association study (GWAS) of LTM response was reported. In this study, DNA and p...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahlin, A, Litonjua, A, Irvin, C G, Peters, S P, Lima, J J, Kubo, M, Tamari, M, Tantisira, K G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668236/
https://www.ncbi.nlm.nih.gov/pubmed/26031901
http://dx.doi.org/10.1038/tpj.2015.34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668236/
https://www.ncbi.nlm.nih.gov/pubmed/26031901
http://dx.doi.org/10.1038/tpj.2015.34

Ejemplares similares